Loading…

Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3

High expression of the aldo-keto reductase enzyme AKR1C3 in the human prostate and breast has implicated it in the development and progression of leukemias and of prostate and breast cancers. Inhibitors are thus of interest as potential drugs. Most inhibitors of AKR1C3 are carboxylic acids, whose tr...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2013-04, Vol.62, p.738-744
Main Authors: Heinrich, Daniel M, Flanagan, Jack U, Jamieson, Stephen M F, Silva, Shevan, Rigoreau, Laurent J M, Trivier, Elisabeth, Raynham, Tony, Turnbull, Andrew P, Denny, William A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:High expression of the aldo-keto reductase enzyme AKR1C3 in the human prostate and breast has implicated it in the development and progression of leukemias and of prostate and breast cancers. Inhibitors are thus of interest as potential drugs. Most inhibitors of AKR1C3 are carboxylic acids, whose transport into cells is likely dominated by carrier-mediated processes. We describe here a series of (piperidinosulfonamidophenyl)pyrrolidin-2-ones as potent (
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2013.01.047